David A. Siegel Aslan Pharmaceuticals LTD Transaction History

Two Sigma Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.11 - $1.86 $21,090 - $35,340	-19,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.78 - $3.41 $25,810 - $49,445	-14,500 Reduced 43.28%	19,000 $34,000
Q2 2021 Aug 16, 2021	BUY	$2.5 - $3.72 $48,500 - $72,168	19,400 Added 137.59%	33,500 $111,000
Q1 2021 May 17, 2021	BUY	$1.86 - $5.25 $26,226 - $74,025	14,100 New	14,100 $47,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $20.9M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.